Cite
HARVARD Citation
Azuma, K. et al. (2018). ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer. Cancer science. 109 (8), pp. 2532-2538. [Online].